- Home
- HURA vs CFBK Comparison
HURA vs CFBK Comparison
Compare HURA & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- CFBK
- Stock Information
- Founded
- HURA 2009
- CFBK 1892
- Country
- HURA United States
- CFBK United States
- Employees
- HURA N/A
- CFBK N/A
- Industry
- HURA
- CFBK Major Banks
- Sector
- HURA
- CFBK Finance
- Exchange
- HURA Nasdaq
- CFBK Nasdaq
- Market Cap
- HURA 145.6M
- CFBK 159.5M
- IPO Year
- HURA N/A
- CFBK 1998
- Fundamental
- Price
- HURA $2.37
- CFBK $25.26
- Analyst Decision
- HURA Strong Buy
- CFBK Buy
- Analyst Count
- HURA 2
- CFBK 1
- Target Price
- HURA $11.50
- CFBK $29.00
- AVG Volume (30 Days)
- HURA 823.7K
- CFBK 33.1K
- Earning Date
- HURA 08-14-2025
- CFBK 10-29-2025
- Dividend Yield
- HURA N/A
- CFBK 1.29%
- EPS Growth
- HURA N/A
- CFBK 36.66
- EPS
- HURA N/A
- CFBK 2.77
- Revenue
- HURA N/A
- CFBK $52,793,000.00
- Revenue This Year
- HURA N/A
- CFBK $39.98
- Revenue Next Year
- HURA N/A
- CFBK $10.47
- P/E Ratio
- HURA N/A
- CFBK $8.93
- Revenue Growth
- HURA N/A
- CFBK 20.91
- 52 Week Low
- HURA $1.80
- CFBK $19.23
- 52 Week High
- HURA $8.40
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- HURA 38.05
- CFBK 64.17
- Support Level
- HURA $2.43
- CFBK $24.28
- Resistance Level
- HURA $2.65
- CFBK $25.97
- Average True Range (ATR)
- HURA 0.18
- CFBK 0.44
- MACD
- HURA -0.07
- CFBK 0.05
- Stochastic Oscillator
- HURA 5.39
- CFBK 58.14
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.